These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19416420)

  • 21. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting adverse drug reactions to improve patient outcomes.
    Hannan TJ
    Int J Med Inform; 1999 Jul; 55(1):61-4. PubMed ID: 10471241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders.
    Palen TE; Raebel M; Lyons E; Magid DM
    Am J Manag Care; 2006 Jul; 12(7):389-95. PubMed ID: 16834525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of nationwide on-line prescription records improves the drug history in hospitalized patients.
    Glintborg B; Poulsen HE; Dalhoff KP
    Br J Clin Pharmacol; 2008 Feb; 65(2):265-9. PubMed ID: 17764470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting.
    Linder JA; Haas JS; Iyer A; Labuzetta MA; Ibara M; Celeste M; Getty G; Bates DW
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1211-5. PubMed ID: 21155192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electronic health record-based monitoring of primary care patients at risk of medication-related toxicity.
    Bundy DG; Marsteller JA; Wu AW; Engineer LD; Berenholtz SM; Caughey AH; Silver D; Tian J; Thompson RE; Miller MR; Lehmann CU
    Jt Comm J Qual Patient Saf; 2012 May; 38(5):216-23. PubMed ID: 22649861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.
    Lorimer S; Cox A; Langford NJ
    J Clin Pharm Ther; 2012 Apr; 37(2):148-52. PubMed ID: 21592157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs.
    Sessa M; Rafaniello C; Sportiello L; Mascolo A; Scavone C; Maccariello A; Iannaccone T; Fabrazzo M; Berrino L; Rossi F; Capuano A
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):9-15. PubMed ID: 27875917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription-event monitoring and reporting of adverse drug reactions.
    Heeley E; Riley J; Layton D; Wilton LV; Shakir SA
    Lancet; 2001 Dec; 358(9296):1872-3. PubMed ID: 11741629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacovigilance in child and adolescent psychiatry].
    Egberts K; Karwautz A; Plener PL; Mehler-Wex C; Kölch M; Dang SY; Taurines R; Romanos M; Gerlach M
    Z Kinder Jugendpsychiatr Psychother; 2015 Jan; 43(1):21-8. PubMed ID: 25536893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of psychotropic medication on sexuality: literature review.
    Higgins A
    Br J Nurs; 2007 May 10-23; 16(9):545-50. PubMed ID: 17551447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rational use of psychoactive substances.
    Rassool GH
    Nurs Stand; 2005 Feb 2-8; 19(21):45-51; quiz 52. PubMed ID: 15727018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mental illness and psychotropic medication use in the nursing home.
    Arling G; Ryther BJ; Collins T; Zimmerman D
    J Aging Health; 1991 Nov; 3(4):455-72. PubMed ID: 10115034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving mental health service users' physical health through medication monitoring: a literature review.
    Nash M
    J Nurs Manag; 2011 Apr; 19(3):360-5. PubMed ID: 21507107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse Events, Drug Interactions, and Treatment Adherence.
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2020 Feb; 58(2):9-13. PubMed ID: 32003860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting of adverse drug reactions: practice in the UK.
    Morrison-Griffiths S; Pirmohamed M; Walley T
    Nurs Times; 1998 Mar 11-17; 94(10):52-4. PubMed ID: 9735778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connections and consequences in complex systems: insights from a case study of the emergence and local impact of crisis resolution and home treatment services.
    Hannigan B
    Soc Sci Med; 2013 Sep; 93():212-9. PubMed ID: 22386638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot National Electronic Cataract Surgery Survey: I. Method, descriptive, and process features.
    Johnston RL; Sparrow JM; Canning CR; Tole D; Price NC
    Eye (Lond); 2005 Jul; 19(7):788-94. PubMed ID: 15375370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring and documentation of side effects from depot antipsychotic medication: an interdisciplinary audit of practice in a regional mental health service.
    Cleary A; Walsh F; Connolly H; Hays V; Oluwole B; Macken E; Dowling M
    J Psychiatr Ment Health Nurs; 2012 Jun; 19(5):395-401. PubMed ID: 22070791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.